US Patent Issued to Sitryx Therapeutics on Oct. 21 for "Phthalazine derivatives as pyruvate kinase modulators" (British Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,367, issued on Oct. 21, was assigned to Sitryx Therapeutics Ltd. (Oxford, Great Britain).

"Phthalazine derivatives as pyruvate kinase modulators" was invented by David Cousin (Nottingham, Great Britain) and Oscar Barba (Oxford, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a compound of formula (Ia):and related aspects."

The patent was filed on Feb. 20, 2025, under Application No. 19/058,521.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12...